Project Grant R21AI199322
- Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $162,000 Project Grant to the University of Rochester on April 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) for a 24-month project period ending March 31, 2028. This award funds research aimed at elucidating the role of genome organization in type 1 conventional dendritic cell (cdc1) development, with specific focus on how cohesin—a protein complex responsible...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Research Foundation for the State University of New York a Project Grant of $240,150 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 24, 2025, with completion scheduled for June 30, 2027. This research initiative investigates the mechanisms by which the Large Tumor-Antigen (LT) protein from polyomaviruses cooperates with the ETS1 proto-oncogene...
- Federal Grant Award Summary New York University School of Medicine received a $466,125 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective January 29, 2026, with a completion date of December 31, 2027. The award supports investigator-initiated biomedical research examining the role of CD69 in established resident memory T cells (TRM)—immune cells that remain at infection...
- Federal Grant Award Summary New York University School of Medicine received a $755,801 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 3, 2026, with a completion date of January 31, 2031. The research investigates the role of CLNS1A protein in regulating CD4+ and CD8+ T cell function, with particular focus on understanding how CLNS1A controls DNA repair and cell...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Research Foundation for the State University of New York a Project Grant of $160,100 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on April 7, 2026. The award supports a pilot research project investigating the functional impact of ZNF688 autoantibodies in oral lupus lesions, specifically examining how autoantibodies targeting the ZNF688 transcription factor may...
- Federal Grant Award Summary The Feinstein Institutes for Medical Research received a $460,625 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 10, 2026, with a completion date of January 31, 2028. The award supports investigator-initiated biomedical research focused on understanding the maturation and maintenance of the germinal center niche, specifically examining...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $161,500 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded April 1, 2026, with completion targeted for March 31, 2028. The award funds the development of new genetic tools—specifically novel Cre and CreERT2 transgenic mouse models—for selective targeting and study of plasma cells...
- Federal Grant Award Summary Cornell University's Office of Sponsored Programs received a Project Grant of $238,810 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on September 1, 2025, with completion scheduled for August 31, 2027. The research project, titled "Embryonic Origins of T Cells," addresses fundamental gaps in understanding T lymphocyte development and function. The grant...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $508,500 Project Grant to New York University School of Medicine on April 22, 2026, for research conducted through the Allergy and Infectious Diseases Research program (CFDA 93.855). This award supports a postdoctoral research initiative aimed at decoding the molecular mechanisms by which myeloid cells, specifically neutrophils, select between distinct functional programs—migration,...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Rochester a $1,042,346 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective January 28, 2026, with completion by December 31, 2030. The project, titled "Critical Developmental Windows and Underlying Processes in Extremely Low Gestational Age Neonates' Immune Trajectories," will deliver research services investigating...
Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $199,524 Project Grant on May 21, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Research Foundation for the State University of New York, with performance at the University at Buffalo. The award funds a genomics research initiative examining the evolutionary origins of germinal center (GC) immune responses through advanced molecular and computational analysis. The research employs single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics to characterize immune cell subsets and their spatial organization in the spleen of the red-eared slider turtle (Trachemys scripta), with the goal of understanding how genes associated with GC development—including AICDA, BCL6, CD40, CD40LG, CXCR5, ICOS, and others—were evolutionarily co-opted to support GC responses in mammals. The project period extends through April 30, 2028. This research addresses a fundamental gap in understanding immunological evolution by investigating genes present in non-mammalian species that lack organized germinal centers, thereby elucidating the regulatory mechanisms and biological adaptations underlying the transition to sophisticated adaptive immune responses in mammals. The deliverables include genomic datasets, bioinformatic analyses, and characterization of immune cell regulatory pathways that may inform understanding of B cell responses relevant to anti-pathogen immunity and vaccine efficacy.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $199.5k | 5/21/26 |